Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What the Research Shows Weight Loss Approaching Bariatric Surgery Levels The SURMOUNT-1 trial [1] showed average weight loss of 22.5% with tirzepatide 15 mg over 72 weeks
This tailored approach ensures that tirzepatide is used effectively to achieve and maintain weight loss goals
For context, 44% of Wegovy-treated participants experienced nausea, 30% diarrhea, and 24% constipation
The evidence is not
"A regular dose every 10 days instead of weekly may give the body more time to recover and acclimate," Hatipoglu says
US$ 21.04
US$ 27.77
US$ 20.17
US$ 28.81
US$ 29.45
